Enhanced Intervertebral Disc Repair Via Genetically Engineered Mesenchymal Stem Cells with Tetracycline Regulatory System

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Nov 25

PMID 38003216

Authors

Yeji Kim

Seong Bae An

Sang-Hyuk Lee

Jong Joo Lee

Sung Bum Kim

Jae-Cheul Ahn

Dong-Youn Hwang

Inbo Han

Affiliations

Soon will be listed here.

Abstract

The therapeutic potential of Mesenchymal stem cells (MSCs) for the treatment of Intervertebral disc (IVD) degeneration can be enhanced by amplifying specific cytokines and proteins. This study aimed to investigate the therapeutic potential of tetracycline-off system-engineered tonsil-derived mesenchymal stem cells (ToMSC-Tetoff-TGFβ1-IGF1-BMP7) for treating intervertebral disc (IVD) degeneration. ToMSCs were isolated from a tonsillectomy patient and genetically modified with four distinct plasmids via CRISPR/Cas9-mediated knock-in gene editing. Transgene expression was confirmed through immunofluorescence, western blots, and an enzyme-linked immunosorbent assay for transforming growth factor beta 1 (TGFβ1) protein secretion, and the effect of MSC-TetOff-TGFβ1-IGF1-BMP7 on disc injury was assessed in a rat model. The ToMSC-Tetoff-TGFβ1-IGF1-BMP7 treatment exhibited superior therapeutic effects compared to ToMSC-TGFβ1, and ToMSC-SDF1α implantation groups, stimulating the regeneration of nucleus pulposus (NP) cells crucial for IVD. The treatment showed potential to restore the structural integrity of the extracellular matrix (ECM) by upregulating key molecules such as aggrecan and type II collagen. It also exhibited anti-inflammatory properties and reduced pain-inducing neuropeptides. ToMSC-Tetoff-TGFβ1-IGF1-BMP7 holds promise as a novel treatment for IVD degeneration. It appears to promote NP cell regeneration, restore ECM structure, suppress inflammation, and reduce pain. However, more research and clinical trials are required to confirm its therapeutic potential.

Citing Articles

Multifunctional extracellular vesicles and edaravone-loaded scaffolds for kidney tissue regeneration by activating GDNF/RET pathway.

Lee S, Park J, Rhim W, Lee E, Lee S, Kim J Nano Converg. 2024; 11(1):43.

PMID: 39460807 PMC: 11512987. DOI: 10.1186/s40580-024-00450-5.

References

Cai F, Zhu L, Wang F, Shi R, Xie X, Hong X . The Paracrine Effect of Degenerated Disc Cells on Healthy Human Nucleus Pulposus Cells Is Mediated by MAPK and NF-κB Pathways and Can Be Reduced by TGF-β1. DNA Cell Biol. 2016; 36(2):143-158. DOI: 10.1089/dna.2016.3230. View

De Geer C . Intervertebral Disk Nutrients and Transport Mechanisms in Relation to Disk Degeneration: A Narrative Literature Review. J Chiropr Med. 2018; 17(2):97-105. PMC: 6112070. DOI: 10.1016/j.jcm.2017.11.006. View

Barakat A, Elwell V, Lam K . Stem cell therapy in discogenic back pain. J Spine Surg. 2020; 5(4):561-583. PMC: 6989932. DOI: 10.21037/jss.2019.09.22. View

Inoue G, Ohtori S, Aoki Y, Ozawa T, Doya H, Saito T . Exposure of the nucleus pulposus to the outside of the anulus fibrosus induces nerve injury and regeneration of the afferent fibers innervating the lumbar intervertebral discs in rats. Spine (Phila Pa 1976). 2006; 31(13):1433-8. DOI: 10.1097/01.brs.0000219946.25103.db. View

Tam V, Chan W, Leung V, Cheah K, Cheung K, Sakai D . Histological and reference system for the analysis of mouse intervertebral disc. J Orthop Res. 2017; 36(1):233-243. DOI: 10.1002/jor.23637. View

Smith L, Silverman L, Sakai D, Le Maitre C, Mauck R, Malhotra N . Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: Recommendations of the ORS spine section. JOR Spine. 2019; 1(4):e1036. PMC: 6419951. DOI: 10.1002/jsp2.1036. View

Shi J, Zhao Y, Niu Z, Fan H, Hou S, Guo X . Mesenchymal stem cell-derived small extracellular vesicles in the treatment of human diseases: Progress and prospect. World J Stem Cells. 2021; 13(1):49-63. PMC: 7859991. DOI: 10.4252/wjsc.v13.i1.49. View

Sun Z, Luo B, Liu Z, Samartzis D, Liu Z, Gao B . Adipose-derived stromal cells protect intervertebral disc cells in compression: implications for stem cell regenerative disc therapy. Int J Biol Sci. 2015; 11(2):133-43. PMC: 4279089. DOI: 10.7150/ijbs.10598. View

Wang S, Yu Y, Tang C, Lv F . Effects of TGF-β1 and IL-1β on expression of ADAMTS enzymes and TIMP-3 in human intervertebral disc degeneration. Exp Ther Med. 2013; 6(6):1522-1526. PMC: 3829724. DOI: 10.3892/etm.2013.1348. View

10.

Mackiewicz Z, Salo J, Konttinen Y, Kaigle Holm A, Indahl A, Pajarinen J . Receptor activator of nuclear factor kappa B ligand in an experimental intervertebral disc degeneration. Clin Exp Rheumatol. 2009; 27(2):299-306. View

11.

Kim H, Hong J, Lee J, Jeon W, Ha I . IL-1β promotes disc degeneration and inflammation through direct injection of intervertebral disc in a rat lumbar disc herniation model. Spine J. 2021; 21(6):1031-1041. DOI: 10.1016/j.spinee.2021.01.014. View

12.

Chuang C, Lin K, Lin C, Chang Y, Yen T, Hwang S . Xenotransplantation of human mesenchymal stem cells into immunocompetent rats for calvarial bone repair. Tissue Eng Part A. 2009; 16(2):479-88. DOI: 10.1089/ten.TEA.2009.0401. View

13.

Vadala G, Russo F, Ambrosio L, Papalia R, Denaro V . Mesenchymal stem cells for intervertebral disc regeneration. J Biol Regul Homeost Agents. 2016; 30(4 Suppl 1):173-179. View

14.

Chan C, Peng P . Failed back surgery syndrome. Pain Med. 2011; 12(4):577-606. DOI: 10.1111/j.1526-4637.2011.01089.x. View

15.

Fernandez-Francos S, Eiro N, Costa L, Escudero-Cernuda S, Fernandez-Sanchez M, Vizoso F . Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine. Int J Mol Sci. 2021; 22(7). PMC: 8036553. DOI: 10.3390/ijms22073576. View

16.

Xing H, Zhang Z, Mao Q, Wang C, Zhou Y, Zhou X . Injectable exosome-functionalized extracellular matrix hydrogel for metabolism balance and pyroptosis regulation in intervertebral disc degeneration. J Nanobiotechnology. 2021; 19(1):264. PMC: 8419940. DOI: 10.1186/s12951-021-00991-5. View

17.

Ryu J, Jeong E, Kim J, Park S, Ju W, Kim C . Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases. Int J Mol Sci. 2020; 21(21). PMC: 7664655. DOI: 10.3390/ijms21218366. View

18.

Ju D, Kanim L, Bae H . Intervertebral Disc Repair: Current Concepts. Global Spine J. 2020; 10(2 Suppl):130S-136S. PMC: 7263334. DOI: 10.1177/2192568219872460. View

19.

Cho K, Park M, Kim Y, Woo S, Ryu K . RNA sequencing reveals a transcriptomic portrait of human mesenchymal stem cells from bone marrow, adipose tissue, and palatine tonsils. Sci Rep. 2017; 7(1):17114. PMC: 5719355. DOI: 10.1038/s41598-017-16788-2. View

20.

Lim S, An S, Jung M, Joshi H, Kumar H, Kim C . Local Delivery of Senolytic Drug Inhibits Intervertebral Disc Degeneration and Restores Intervertebral Disc Structure. Adv Healthc Mater. 2021; 11(2):e2101483. DOI: 10.1002/adhm.202101483. View